AI-generated summary
The authors report a randomised double-blind trial in 102 patients with non-seasonal major depression, all taking sertraline, comparing 5 weeks of bright white light with dim red light. Clinician-rated depression scores fell more in the bright light group on all scales, and the authors say the results support bright light as an adjunct to antidepressants.
- Participants
- 102
- Who or what was studied
- Adults with non-seasonal major depression receiving sertraline 50 mg daily
- Limits stated in the abstract
- The abstract does not describe the wavelengths of the light used or any limits on the trial design beyond its single-centre, five-week scope.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Lux, Bright light therapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.